Dr Jong-wook Ban, MD | |
1010 S Scheuber Rd Ste 3&4, Centralia, WA 98531-8892 | |
(360) 827-7966 | |
(360) 827-7977 |
Full Name | Dr Jong-wook Ban |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 27 Years |
Location | 1010 S Scheuber Rd Ste 3&4, Centralia, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265467930 | NPI | - | NPPES |
8417925 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD00044103 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Assured Home Health And Hospice | Centralia, WA | Home health agency |
Providence Sound Homecare & Hospice | Lacey, WA | Home health agency |
Assured Home Health, Hospice & Home Care | Centralia, WA | Hospice |
Providence Centralia Hospital | Centralia, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Health And Services Washington | 6709782600 | 393 |
News Archive
The Associated Press: Thirty-three people have been charged in Buffalo, N.Y., "in a large-scale investigation that has opened a window into an emerging class of suppliers in the illicit drug trade: medical patients, including many who rely on the publicly funded Medicaid program to pay for their appointments and prescriptions" who sell their prescription drugs.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in the European Union.
The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.
In an editorial published online today in BMJ, Johns Hopkins bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India's new policy protecting research participants.
› Verified 6 days ago
Entity Name | Providence Health & Services Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
The Associated Press: Thirty-three people have been charged in Buffalo, N.Y., "in a large-scale investigation that has opened a window into an emerging class of suppliers in the illicit drug trade: medical patients, including many who rely on the publicly funded Medicaid program to pay for their appointments and prescriptions" who sell their prescription drugs.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in the European Union.
The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.
In an editorial published online today in BMJ, Johns Hopkins bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India's new policy protecting research participants.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jong-wook Ban, MD Po Box 3360, Portland, OR 97208-3360 Ph: () - | Dr Jong-wook Ban, MD 1010 S Scheuber Rd Ste 3&4, Centralia, WA 98531-8892 Ph: (360) 827-7966 |
News Archive
The Associated Press: Thirty-three people have been charged in Buffalo, N.Y., "in a large-scale investigation that has opened a window into an emerging class of suppliers in the illicit drug trade: medical patients, including many who rely on the publicly funded Medicaid program to pay for their appointments and prescriptions" who sell their prescription drugs.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in the European Union.
The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.
In an editorial published online today in BMJ, Johns Hopkins bioethicist Jeremy Sugarman and other experts warn that action is urgently needed to deal with possible unintended consequences of India's new policy protecting research participants.
› Verified 6 days ago
Dr. Richard Scott Elloway, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 S. Scheuber Road, Suite G, Centralia, WA 98531 Phone: 360-330-8808 Fax: 360-330-8816 | |
David Fick, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 914 S Scheuber Rd, Centralia, WA 98531 Phone: 360-736-2803 | |
Eric S Swanson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 S Scheuber Rd, Centralia, WA 98531 Phone: 360-827-8811 | |
Dr. Romil Wadhawan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 S Scheuber Rd, Suite 3&4, Centralia, WA 98531 Phone: 360-807-7966 Fax: 360-807-7977 | |
Dr. Floyd D Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1611 Kresky Ave, Suite 112, Centralia, WA 98531 Phone: 360-330-2023 Fax: 360-623-1585 | |
Katie Elizabeth Kunnen, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 S Scheuber Rd, Centralia, WA 98531 Phone: 360-827-8811 Fax: 360-330-8969 |